Blueprint Medicines Corporation

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11
Rok finansowy 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 11 28 21 45 67 794 180 204 249 509
Przychód Δ r/r 0.0% 0.0% inf% 143.6% -22.9% 107.8% 49.4% 1093.4% -77.3% 13.3% 22.2% 104.0%
Marża brutto 0.0% 0.0% 100.0% 100.0% 100.0% 100.0% 100.0% 99.9% 90.0% 91.3% 90.2% 96.0%
EBIT (mln) -21 -40 -53 -74 -149 -247 -367 302 -648 -549 -486 -212
EBIT Δ r/r 0.0% 91.7% 33.1% 38.8% 103.1% 65.3% 48.4% -182.4% -314.6% -15.3% -11.5% -56.4%
EBIT (%) 0.0% 0.0% -465.1% -265.0% -697.6% -554.9% -551.2% 38.1% -360.1% -269.2% -195.0% -41.7%
Koszty finansowe (mln) 0 0 1 0 0 0 14 0 0 17 52 69
EBITDA (mln) -20 -39 -52 -72 -148 -237 -361 309 -642 -538 -475 -212
EBITDA(%) 0.0% 0.0% -456.8% -259.3% -690.3% -531.4% -543.2% 38.9% -356.5% -263.4% -190.3% -41.7%
Podatek (mln) 0 0 -1 -1 2 10 -19 1 3 5 1 1
Zysk Netto (mln) -21 -40 -53 -72 -148 -237 -329 314 -644 -558 -507 -67
Zysk netto Δ r/r 0.0% 92.6% 31.0% 37.4% 104.3% 59.8% 38.9% -195.5% -305.2% -13.4% -9.1% -86.8%
Zysk netto (%) 0.0% 0.0% -462.9% -261.0% -691.3% -531.5% -494.2% 39.5% -357.7% -273.2% -203.3% -13.2%
EPS -1.6 -3.08 -2.89 -2.64 -3.92 -5.39 -6.87 5.76 -11.01 -9.35 -8.37 -1.07
EPS (rozwodnione) -1.6 -3.08 -2.89 -2.64 -3.92 -5.39 -6.87 5.59 -11.01 -9.35 -8.37 -1.07
Ilośc akcji (mln) 13 13 18 27 38 44 48 55 59 60 61 63
Ważona ilośc akcji (mln) 13 13 18 27 38 44 48 56 59 60 61 63
Waluta USD USD USD USD USD USD USD USD USD USD USD USD